# DETEC® Esterase for Screening Wound Infection at Point of Care

> **NCT04614870** · — · UNKNOWN · sponsor: **Progenitec Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Diabetic Foot Ulcer
- Venous Leg Ulcer
- Pressure Ulcer

## Interventions

- **DIAGNOSTIC_TEST:** DETEC® Esterase

## Key facts

- **NCT ID:** NCT04614870
- **Lead sponsor:** Progenitec Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04614870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04614870, "DETEC® Esterase for Screening Wound Infection at Point of Care". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04614870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*